<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2d1 20170631//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="article" dtd-version="1.2d1" specific-use="production" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">MEDRXIV</journal-id>
<journal-title-group>
<journal-title>medRxiv</journal-title>
<abbrev-journal-title abbrev-type="publisher">medRxiv</abbrev-journal-title>
</journal-title-group>
<publisher>
<publisher-name>Cold Spring Harbor Laboratory</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1101/2020.09.28.20203166</article-id>
<article-version>1.2</article-version>
<article-categories>
<subj-group subj-group-type="hwp-journal-coll">
<subject>Infectious Diseases (except HIV/AIDS)</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Comparison of infection control strategies to reduce COVID-19 outbreaks in homeless shelters in the United States</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7727-7102</contrib-id>
<name><surname>Chapman</surname><given-names>Lloyd A.C.</given-names></name>
<degrees>PhD</degrees>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="corresp" rid="cor1">&#x002A;</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1361-6889</contrib-id>
<name><surname>Kushel</surname><given-names>Margot</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Cox</surname><given-names>Sarah N.</given-names></name>
<degrees>MSPH</degrees>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Scarborough</surname><given-names>Ashley</given-names></name>
<degrees>MPH</degrees>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0956-0632</contrib-id>
<name><surname>Cawley</surname><given-names>Caroline</given-names></name>
<degrees>MPH</degrees>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Nguyen</surname><given-names>Trang</given-names></name>
<degrees>MPH PhD</degrees>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-6784-1021</contrib-id>
<name><surname>Rodriguez-Barraquer</surname><given-names>Isabel</given-names></name>
<degrees>MD PhD</degrees>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0287-9111</contrib-id>
<name><surname>Greenhouse</surname><given-names>Bryan</given-names></name>
<degrees>MD</degrees>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Imbert</surname><given-names>Elizabeth</given-names></name>
<degrees>MD MPH</degrees>
<xref ref-type="aff" rid="a5">5</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5407-2005</contrib-id>
<name><surname>Lo</surname><given-names>Nathan C.</given-names></name>
<degrees>MD PhD</degrees>
<xref ref-type="aff" rid="a1">1</xref>
</contrib>
<aff id="a1"><label>1</label><institution>Department of Medicine, University of California</institution>, San Francisco, San Francisco, CA, <country>USA</country></aff>
<aff id="a2"><label>2</label><institution>Center for Vulnerable Populations, Zuckerberg San Francisco General Hospital and Trauma Center, University of California</institution>, San Francisco, San Francisco, CA, <country>USA</country></aff>
<aff id="a3"><label>3</label><institution>San Francisco Department of Public Health</institution>, San Francisco, CA, <country>USA</country></aff>
<aff id="a4"><label>4</label><institution>Department of Emergency Medicine, University of California</institution>, San Francisco, San Francisco, CA, <country>USA</country></aff>
<aff id="a5"><label>5</label><institution>Division of HIV, Infectious Diseases, and Global Medicine, University of California</institution>, San Francisco, San Francisco, CA, <country>USA</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><label>&#x002A;</label>Correspondence Lloyd A.C. Chapman, PhD and Nathan C. Lo, MD PhD, University of California, San Francisco, Department of Medicine, San Francisco, CA, USA 94110, <email>Lloyd.Chapman@ucsf.edu</email></corresp>
<fn fn-type="confilct"><p><bold>Conflicts of Interest:</bold> The authors declare no conflicts of interest.</p></fn>
<fn fn-type="other"><p><bold>Email:</bold> Dr Lloyd A.C. Chapman (<email>Lloyd.Chapman@ucsf.edu</email>) Dr Nathan C. Lo (<email>Nathan.Lo@ucsf.edu</email>)</p></fn>
</author-notes>
<pub-date pub-type="epub">
<year>2020</year>
</pub-date>
<elocation-id>2020.09.28.20203166</elocation-id>
<history>
<date date-type="received">
<day>28</day>
<month>9</month>
<year>2020</year>
</date>
<date date-type="rev-recd">
<day>23</day>
<month>10</month>
<year>2020</year>
</date>
<date date-type="accepted">
<day>23</day>
<month>10</month>
<year>2020</year>
</date>
</history>
<permissions>
<copyright-statement>&#x00A9; 2020, Posted by Cold Spring Harbor Laboratory</copyright-statement>
<copyright-year>2020</copyright-year>
<license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p>This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link></license-p></license>
</permissions>
<self-uri xlink:href="20203166.pdf" content-type="pdf" xlink:role="full-text"/>
<abstract>
<title>Abstract</title>
<sec>
<title>Background</title>
<p>Multiple COVID-19 outbreaks have occurred in homeless shelters across the US, highlighting an urgent need to identify the most effective infection control strategy to prevent future outbreaks.</p></sec>
<sec>
<title>Methods</title>
<p>We developed a microsimulation model of SARS-CoV-2 transmission in a homeless shelter and calibrated it to data from cross-sectional polymerase-chain-reaction (PCR) surveys conducted during COVID-19 outbreaks in five shelters in three US cities from March 28 to April 10, 2020. We estimated the probability of averting a COVID-19 outbreak in a representative homeless shelter of 250 residents and 50 staff over 30 days under different infection control strategies, including daily symptom-based screening, twice-weekly PCR testing and universal mask wearing.</p></sec>
<sec>
<title>Results</title>
<p>Basic reproduction number (<italic>R</italic><sub>0</sub>) estimates for the observed outbreaks ranged from 2.9 to 6.2. The probability of averting an outbreak diminished with higher transmissibility (<italic>R</italic><sub>0</sub>) within the simulated shelter and increasing incidence in the local community. With moderate community incidence (&#x223C;30 confirmed cases/1,000,000 people/day), the estimated probabilities of averting an outbreak in a low-risk (<italic>R</italic><sub>0</sub>=1.5), moderate-risk (<italic>R</italic><sub>0</sub>=2.9), and high-risk (<italic>R</italic><sub>0</sub>=6.2) shelter were: 0.33, 0.11 and 0.03 for daily symptom-based screening; 0.52, 0.27, and 0.04 for twice-weekly PCR testing; 0.47, 0.20 and 0.06 for universal masking; and 0.68, 0.40 and 0.08 for these strategies combined.</p></sec>
<sec>
<title>Conclusions</title>
<p>In high-risk homeless shelter environments and locations with high community incidence of COVID-19, even intensive infection control strategies are unlikely to prevent outbreaks, suggesting a need for non-congregate housing arrangements for people experiencing homelessness. In lower-risk environments, combined interventions should be adopted to reduce outbreak risk.</p></sec>
<sec>
<title>Summary</title>
<p>Combining symptom-screening, twice-weekly PCR testing and universal masking is unlikely to prevent COVID-19 outbreaks in high-risk congregate homeless shelters and settings with high community incidence, but may be sufficient in lower-risk settings. Alternative housing arrangements are needed in high-risk settings.</p></sec>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords</title>
<kwd>COVID-19</kwd>
<kwd>homelessness</kwd>
<kwd>shelters</kwd>
<kwd>infection control</kwd>
<kwd>outbreaks</kwd>
</kwd-group>
<counts>
<page-count count="27"/>
</counts>
</article-meta>
<notes>
<notes notes-type="competing-interest-statement">
<title>Competing Interest Statement</title><p>The authors have declared no competing interest.</p></notes>
<notes notes-type="financial-disclosure">
<title>Funding Statement</title><p>This work was supported by the University of California, San Francisco (UCSF) and the UCSF Benioff Homelessness and Housing Initiative. The funders had no role in the study design, data collection and analysis, preparation of the manuscript, or the decision to submit the manuscript for publication.</p></notes>
<notes notes-type="disclosures">
<title>Author Declarations</title><p>I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.</p><p>Yes</p><p>The details of the IRB/oversight body that provided approval or exemption for the research described are given below:</p><p>This study was considered exempt non-human subject research based on use of de-identified secondary data by the University of California, San Francisco Institutional Review Board</p><p>All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.</p><p>Yes</p><p>I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).</p><p>Yes</p><p>I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.</p><p>Yes</p></notes>
</notes>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>The COVID-19 pandemic caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) poses great risk to people experiencing homelessness. Across the US, the estimated 568,000 people who experience homelessness nightly [<xref ref-type="bibr" rid="c1">1</xref>] are likely to suffer a disproportionate disease burden and need for hospitalization [<xref ref-type="bibr" rid="c2">2</xref>,<xref ref-type="bibr" rid="c3">3</xref>]. People experiencing homelessness are on average older and have a high prevalence of comorbidities that are risk factors for severe COVID-19 [<xref ref-type="bibr" rid="c2">2</xref>]. Multiple outbreaks in homeless shelters have occurred in several cities including San Francisco, Boston, Seattle and Atlanta with attack rates of up to 67&#x0025; [<xref ref-type="bibr" rid="c4">4</xref>&#x2013;<xref ref-type="bibr" rid="c7">7</xref>]. Homeless shelters have had to remain open in most cities despite high incidence of infection in the community, concern about the risk of further outbreaks, and uncertainty over the effectiveness of different infection control strategies. There is an immediate need to identify the best infection control strategy to reduce the risk of outbreaks and assess the safety of continuing to operate congregate shelters where transmission in the community is high.</p>
<p>The role of shelters and associated infection control practices in transmission of COVID-19 among people experiencing homelessness is still poorly understood. Given current understanding that SARS-CoV-2 virus is transmitted predominantly through respiratory droplets, with some airborne and fomite transmission [<xref ref-type="bibr" rid="c8">8</xref>], there is a need to consider policies to limit transmission within high-density congregate living environments. Different infection control strategies are currently recommended based on the level of transmission in the external community [<xref ref-type="bibr" rid="c9">9</xref>]. These include routine symptom screening, polymerase chain reaction (PCR) testing, universal mask wearing, and relocation of individuals at high risk of severe disease to non-congregate settings [<xref ref-type="bibr" rid="c10">10</xref>]. There is limited evidence on the effectiveness of strategies to reduce transmission in congregate settings, and thus further research is urgently needed to guide city-level policy across the US.</p>
<p>The goal of this study is to identify the most effective infection control strategy to slow the spread of COVID-19 among people experiencing homelessness who reside in shelters. We address this pressing question by estimating comparative health outcomes of key infection control strategies using a simulation model calibrated to data on homeless shelter outbreaks.</p>
</sec>
<sec id="s2">
<title>Methods</title>
<sec id="s2a">
<title>Microsimulation model</title>
<p>We developed an individual-level stochastic susceptible-exposed-infectious-recovered (SEIR) model [<xref ref-type="bibr" rid="c11">11</xref>] to simulate transmission of SARS-CoV-2 in a congregate shelter population (Supplementary Figure 1). The model defines individuals as susceptible, exposed, infectious, or immune to SARS-CoV-2 (Supplementary Table 1). We constructed the model to include important aspects of the natural history of COVID-19, including sub-clinical infection, pre-symptomatic transmission, and age-specific differences in risk of severe symptoms. In the model, susceptible individuals become infected with SARS-CoV-2 at a rate proportional to the prevalence of infectious individuals inside the shelter and their infectiousness (assuming homogeneous mixing), plus a static force of infection based on the background infection incidence in the community outside the shelter. Upon infection, individuals enter a latent infection stage in which they incubate the virus but are not infectious. They then progress to become infectious and contribute to ongoing transmission. An age-dependent fraction of infected individuals develop clinical symptoms with associated risk of hospitalization and death (Supplementary Table 2), while the remainder have sub-clinical infection. Individuals who recover from infection are assumed to remain immune.</p>
</sec>
<sec id="s2b">
<title>Data</title>
<p>The model was calibrated using aggregate data from PCR testing conducted during COVID-19 outbreaks in five shelters in three US cities &#x2013; San Francisco (n=1), Boston (n=1) and Seattle (n=3) [<xref ref-type="bibr" rid="c4">4</xref>,<xref ref-type="bibr" rid="c6">6</xref>,<xref ref-type="bibr" rid="c7">7</xref>] &#x2013; from March 28&#x2013;April 10, 2020. We obtained de-identified individual-level data from the outbreak in the San Francisco shelter (see Supplementary Material and Supplementary Table 3 for details), which is fully described elsewhere [<xref ref-type="bibr" rid="c5">5</xref>]. As of April 10, 2020, a total of 89 individuals (84 residents, 5 staff) of 175 tested (130 residents, 45 staff) in the shelter were PCR-positive. We obtained aggregate data from the outbreaks in the Boston and Seattle shelters, where identified COVID-19 cases triggered mass testing events [<xref ref-type="bibr" rid="c4">4</xref>,<xref ref-type="bibr" rid="c6">6</xref>,<xref ref-type="bibr" rid="c7">7</xref>]. In the Boston shelter, 147 of 408 residents and 15 of 50 staff were PCR-positive during testing conducted April 2&#x2013;3, 2020. The numbers of residents and staff tested and positive in the three Seattle shelters (shelters A, B and C) at two testing events conducted March 30&#x2013;April 1 and April 7&#x2013;8, 2020 are given in Supplementary Table 4.</p>
</sec>
<sec id="s2c">
<title>Model calibration</title>
<p>We calibrated the model to the aggregate numbers of individuals PCR-positive out of those tested in each shelter (daily data for the San Francisco shelter, cross-sectional for the Seattle and Boston shelters) using approximate Bayesian computation techniques (see Supplementary Material). We fitted the following parameters: (i) the basic reproduction number <italic>R</italic><sub>0</sub> (the average number of secondary infections generated by the average infectious individual in an entirely susceptible shelter population), (ii) the number of latently infected individuals who initially entered the shelter <italic>E</italic><sub>0</sub>, and (iii) the number of days before the first case was identified that these individuals entered the shelter <italic>D</italic> (<xref rid="tbl1" ref-type="table">Table 1</xref>). The remaining parameters were sourced from literature on natural history and epidemiology of SARS-CoV-2 (<xref rid="tbl1" ref-type="table">Table 1</xref> and Supplementary Table 5).</p>
<table-wrap id="tbl1" orientation="portrait" position="float">
<label>Table 1.</label>
<caption><p>Microsimulation input parameters based on observed outbreak data from homeless shelters in Seattle, Boston and San Francisco</p></caption>
<graphic xlink:href="20203166v2_tbl1.tif"/>
</table-wrap>
</sec>
<sec id="s2d">
<title>Infection control strategies</title>
<p>We simulated six infection control strategies (Supplementary Table 6). 1) <italic>Daily symptom-based screening</italic>: daily screening of all individuals in the shelter involving a temperature and symptom survey. Individuals who screened positive were PCR tested, with 80&#x0025; compliance, and isolated for 1 day pending the test result; if negative, they returned to the population. We used published data on the sensitivity of symptom-based screening with time since infection [<xref ref-type="bibr" rid="c12">12</xref>], which suggests that close to 100&#x0025; of symptomatic cases (a subset of all true cases) would eventually be detected under repeated daily screening based on the definition of being symptomatic, even with low sensitivity of symptom screening on any one occasion (here assumed to be 40&#x0025; to give a 98&#x0025; probability of detection after 8 days of daily symptom screening). Despite reports of low specificity of symptom screening [<xref ref-type="bibr" rid="c13">13</xref>,<xref ref-type="bibr" rid="c14">14</xref>], a high specificity of 90&#x0025; was assumed to prevent unrealistic levels of PCR testing and isolation of symptom-positive individuals awaiting test results. We assumed a minimum of 3 days between repeat PCR tests for the same individual based on typical clinical practice and test turnaround times. 2) <italic>Routine PCR testing</italic>: twice-weekly PCR testing of residents and staff based on prior literature analyzing reduction in transmission and cost-effectiveness under different testing frequencies [<xref ref-type="bibr" rid="c15">15</xref>&#x2013;<xref ref-type="bibr" rid="c17">17</xref>]. We assumed 75&#x0025; sensitivity and 100&#x0025; specificity of PCR testing based on published literature [<xref ref-type="bibr" rid="c18">18</xref>&#x2013;<xref ref-type="bibr" rid="c21">21</xref>], a mean duration of detectable viral load (starting prior to development of symptoms) of 20 days (Supplementary Figure 3) [<xref ref-type="bibr" rid="c22">22</xref>&#x2013;<xref ref-type="bibr" rid="c27">27</xref>], and 80&#x0025; compliance with testing. We assumed test results were returned in 1 day, after which time individuals who tested PCR-positive were removed from the shelter population. 3) <italic>Universal mask wearing</italic>: wearing of surgical masks by all persons within the shelter. We assumed that surgical mask wearing reduced the amount of infectious SARS-CoV-2 material breathed into the air by infected individuals by 30&#x0025; based on literature estimates from household studies assuming high compliance and recent experimental studies [<xref ref-type="bibr" rid="c28">28</xref>&#x2013;<xref ref-type="bibr" rid="c33">33</xref>], and that 80&#x0025; of individuals adhered to mask wearing [<xref ref-type="bibr" rid="c34">34</xref>&#x2013;<xref ref-type="bibr" rid="c36">36</xref>]. 4) <italic>Relocation of &#x201C;high-risk&#x201D; individuals</italic>: moving high-risk individuals (defined as those &#x2265;60 years and/or with co-morbidities) to single hotel rooms, modelled by replacing such individuals with lower-risk individuals. 5) <italic>Routine PCR testing of staff only</italic>: twice-weekly testing of staff only, assuming 80&#x0025; compliance. 6) <italic>Combination strategy</italic>: strategies 1&#x2013;4 combined. Daily symptom screening (strategy 1) was included in all strategies.</p>
</sec>
<sec id="s2e">
<title>Prediction of impact of infection control strategies</title>
<p>For each intervention strategy we simulated transmission within a shelter of 250 residents and 50 staff (based on an average shelter size) over 30 days starting with one latently infected individual 1000 times (to account for stochastic uncertainty). The time period was chosen to capture the trajectory of an outbreak and differential benefits of strategies. The primary outcome was the probability of averting an outbreak (defined as 3 or more infections originating within the shelter in any 14-day period [<xref ref-type="bibr" rid="c37">37</xref>,<xref ref-type="bibr" rid="c38">38</xref>]) under each strategy, with secondary outcomes of the proportional reductions in the total numbers of COVID-19 infections and clinical cases, and total numbers of hospitalizations, deaths and PCR tests used. Only individuals who tested positive were removed from the shelter population. The initial population was chosen to have the same composition in terms of proportions in different risk groups (by age and co-morbidity status) as the San Francisco shelter. We estimated the probability of averting an outbreak under each intervention strategy (compared with no interventions) for each calibrated <italic>R</italic><sub>0</sub> value for a range of different background infection rates estimated from recent incidence of confirmed cases in Seattle, Boston and San Francisco (see Supplementary Material for details). To account for potential upward bias in the estimated <italic>R</italic><sub>0</sub> range due to fitting to data from shelters with high attack rates, we performed the same simulations for a shelter environment with a low <italic>R</italic><sub>0</sub> of 1.5. Analyzed data and model code are available at <ext-link ext-link-type="uri" xlink:href="https://github.com/LloydChapman/COVID_homeless_modelling">https://github.com/LloydChapman/COVID_homeless_modelling</ext-link>. This study was considered exempt non-human subject research based on use of de-identified secondary data by the University of California, San Francisco Institutional Review Board.</p>
</sec>
<sec id="s2f">
<title>Sensitivity analysis</title>
<p>We conducted a multi-way sensitivity analysis to assess the impact of uncertainty in key natural history and intervention parameters (relative infectiousness of subclinical infection and the early infectious stage, sensitivities and specificities of symptom screening and PCR tests, testing and masking compliances, and mask effectiveness) on the results (<xref rid="tbl1" ref-type="table">Table 1</xref>). We explored the impact of PCR testing frequency on the probability of averting an outbreak by varying the testing frequency in strategy 2 from daily to monthly.</p>
</sec>
</sec>
<sec id="s3">
<title>Results</title>
<sec id="s3a">
<title>Model calibration</title>
<p>The model reproduced the numbers of PCR-positive individuals in the cross-sectional surveys in the Seattle and Boston shelters (Supplementary Figure 4) and the observed numbers of PCR-positive individuals and symptomatic cases over time for the outbreak in the San Francisco shelter (Supplementary Figures 4 and 5). The estimated <italic>R</italic><sub>0</sub> values ranged from 2.9 (95&#x0025; CI 1.1&#x2013; 6.7) for Seattle shelter B to 6.2 (95&#x0025; CI 4.0&#x2013;7.9) for the San Francisco shelter (Supplementary Table 7), with corresponding estimated cumulative infection incidences at the end of the testing period of 14&#x0025; (95&#x0025; CI 1&#x2013;41&#x0025;) and 83&#x0025; (95&#x0025; CI 72&#x2013;92&#x0025;) (Supplementary Table 8). The median estimated number of infections initially introduced was 3 for all shelters (95&#x0025; CI 1&#x2013;5). The estimated date of introduction of infection ranged from 10 days (95&#x0025; CI 7&#x2013;14 days) before the first case was identified for Seattle shelter B to 21 days (95&#x0025; CI 17&#x2013;26 days) before for San Francisco.</p>
</sec>
<sec id="s3b">
<title>Impact of infection control strategies</title>
<p><xref rid="tbl2" ref-type="table">Table 2</xref> shows the projected impact of the six infection control strategies considered, for different transmission environments. Daily symptom screening performed poorly across different transmissibilities (probability of averting an outbreak = 0.03 for San Francisco <italic>R</italic><sub>0</sub> = 6.2, and probability = 0.33 for <italic>R</italic><sub>0</sub> = 1.5). Relocating individuals at high-risk of clinical symptoms combined with symptom screening performed similarly to symptom screening alone (probability of averting an outbreak = 0.03&#x2013;0.33 for <italic>R</italic><sub>0</sub> = 6.2&#x2013;1.5). Twice-weekly PCR testing of staff provided some additional benefit over daily symptom screening at lower transmissibilities (probability of averting an outbreak = 0.03&#x2013;0.40 for <italic>R</italic><sub>0</sub> = 6.2&#x2013;1.5). Universal masking and twice-weekly PCR testing of all individuals yielded higher probabilities of averting an outbreak of 0.06&#x2013;0.47 and 0.04&#x2013;0.52 for <italic>R</italic><sub>0</sub> = 6.2&#x2013;1.5. The combination strategy involving daily symptom screening, twice-weekly PCR testing of all individuals, universal masking, and removal of high-risk individuals gave the highest probability of averting an outbreak (0.08&#x2013;0.68 for <italic>R</italic><sub>0</sub> = 6.2&#x2013;1.5).</p>
<table-wrap id="tbl2" orientation="portrait" position="float">
<label>Table 2.</label>
<caption><p>Probability of averting an outbreak<sup>&#x0002A;</sup> over a 30-day period in a generalized homeless shelter&#x2020; with simulated infection control strategies</p></caption>
<graphic xlink:href="20203166v2_tbl2.tif"/>
</table-wrap>
<p>The probability of averting an outbreak under each intervention strategy decreased with increasing transmission potential (<italic>R</italic><sub>0</sub>) inside the shelter and with increasing infection incidence in the community outside the shelter (<xref rid="fig1" ref-type="fig">Figure 1</xref>). Even under the combination strategy, the probability of averting an outbreak in an average-transmission-potential shelter (<italic>R</italic><sub>0</sub> = 2.9) decreased from 0.58 to 0.07 as the background infection rate increased from 0 to 439 cases per 1 million person-days (the estimated background infection rate in San Francisco between June 27 and July 10, 2020).</p>
<fig id="fig1" position="float" fig-type="figure">
<label>Figure 1.</label>
<caption><title>Impact of incidence of infection in the community on the probability of averting an outbreak in a generalized homeless shelter under different intervention strategies for different <italic>R</italic><sub>0</sub> values.</title>
<p>The probability of averting an outbreak (&#x2265;3 infections over any 14-day period) in a generalized homeless shelter of 250 residents and 50 staff over 30 days was estimated for different infection incidences in the community using the microsimulation model described in the text. SF = San Francisco.</p></caption>
<graphic xlink:href="20203166v2_fig1.tif"/>
</fig>
<p>The relative reduction in infection incidence under the different infection control strategies followed the same pattern as the probability of averting an outbreak (Supplementary Table 10 and <xref rid="fig2" ref-type="fig">Figure 2</xref>).</p>
<fig id="fig2" position="float" fig-type="figure">
<label>Figure 2.</label>
<caption><title>Predicted number of COVID-19 infections over a 30-day period in a generalized homeless shelter under different infection control strategies for different <italic>R</italic><sub>0</sub> values.</title>
<p>Solid lines show mean daily numbers of new infections and shaded areas show minimum and maximum daily numbers over 1000 simulations. Background infection rate in the community outside the shelter of approximately 120 infections/1,000,000 person-days. SF = San Francisco.</p></caption>
<graphic xlink:href="20203166v2_fig2.tif"/>
</fig>
<p>PCR test requirements were approximately three times higher (at an average of 6.6 tests per person per month) under twice-weekly PCR testing of all individuals than when only testing individuals identified as symptomatic in daily symptom screening (2.0 tests/person/month), and approximately two times higher than when only testing staff twice-a-week (2.8 tests/person/month) (Supplementary Table 11).</p>
</sec>
<sec id="s3c">
<title>Sensitivity analysis</title>
<p>The probability of averting an outbreak was most sensitive to uncertainty in mask effectiveness and relative infectiousness of the early infectious stage, followed by PCR sensitivity and masking and testing compliances (Supplement Figure 9). Decreasing the frequency of PCR testing from daily to monthly decreased the probability of averting an outbreak for <italic>R</italic><sub>0</sub> = 1.5, 2.9 and 3.9 from 0.70 to 0.35, 0.27 to 0.12, and 0.23 to 0.08 respectively, but had little impact on the already low probability of averting an outbreak for <italic>R</italic><sub>0</sub> = 6.2 (<xref rid="fig3" ref-type="fig">Figure 3</xref>).</p>
<fig id="fig3" position="float" fig-type="figure">
<label>Figure 3.</label>
<caption><title>Impact of varying the frequency of routine PCR testing of residents and staff on the probability of averting an outbreak in a generalized homeless shelter for different <italic>R</italic><sub>0</sub> values.</title>
<p>The probability of averting an outbreak (&#x2265;3 infections over any 14-day period) over 30 days was estimated for different frequencies of routine PCR testing from daily (1 day between tests) to monthly (30 days between tests). Background infection rate in the local community of approximately 120 infections/1,000,000 person-days. SF = San Francisco.</p></caption>
<graphic xlink:href="20203166v2_fig3.tif"/>
</fig>
</sec>
</sec>
<sec id="s4">
<title>Discussion</title>
<p>Several outbreaks of COVID-19 with high attack rates have occurred in homeless shelters across the US, and there remains uncertainty over the best infection control strategies to reduce outbreak risk in shelters. In this study, we applied a simulation analysis to identify infection control strategies to prevent future outbreaks. We found that in high-risk shelters that are unable to maximize basic infection control practices that sufficiently reduce the transmissibility of SARS-CoV-2 (e.g. social distancing, reduced living density), no additional infection control strategy is likely to prevent outbreaks. In contrast, in lower-risk shelters with low background community incidence, the implementation of strategies such as symptom screening, routine PCR testing, and masking would help reduce outbreak risk.</p>
<p>We found a wide range of transmissibility of SARS-CoV-2 based on observed outbreaks in homeless shelters, which greatly affects intervention impact. Basic reproduction number (<italic>R</italic><sub>0</sub>) estimates ranged from 2.9 to 6.2, which is at the high end of estimates in the literature [<xref ref-type="bibr" rid="c39">39</xref>&#x2013;<xref ref-type="bibr" rid="c42">42</xref>]. This likely reflects a high degree of heterogeneity in infectiousness between individuals [<xref ref-type="bibr" rid="c41">41</xref>,<xref ref-type="bibr" rid="c43">43</xref>&#x2013; <xref ref-type="bibr" rid="c46">46</xref>] and a highly conducive environment for transmission within these shelters due to lack of existing infection control practices and high living density. Our <italic>R</italic><sub>0</sub> estimates are also likely not entirely representative of general transmission potential in shelters as non-outbreaks and smaller outbreaks may go undetected or unreported, and some shelters have reported only low numbers of infections [<xref ref-type="bibr" rid="c4">4</xref>,<xref ref-type="bibr" rid="c47">47</xref>]. For these <italic>R</italic><sub>0</sub> values and current background infection rates, we found that the infection control strategies considered are unlikely to prevent outbreaks (probability &#x003C; 40&#x0025;), even when combined. Nevertheless, they do reduce incidence of infection and clinical disease and slow the growth of the outbreak (<xref rid="fig2" ref-type="fig">Figure 2</xref>).</p>
<p>In a lower transmissibility setting, with <italic>R</italic><sub>0</sub> = 1.5, e.g. where staff and clients are able to socially distance, the considered intervention strategies are more likely to prevent outbreaks (probability up to nearly 70&#x0025; under combined interventions, for a moderate background infection rate equivalent to that in Boston in early July of 122/1,000,000/day).</p>
<p>A key remaining issue is identifying the characteristics that distinguish low-risk shelters that can be safely operated with implementation of infection control strategies. Data is limited, but available evidence suggests that social distancing and reductions in super-spreading are likely to be key factors [<xref ref-type="bibr" rid="c41">41</xref>,<xref ref-type="bibr" rid="c43">43</xref>,<xref ref-type="bibr" rid="c48">48</xref>&#x2013;<xref ref-type="bibr" rid="c50">50</xref>]. Strategies that may achieve these goals include reducing living density, spacing bedding, reducing communal activities, and adopting staffing models that limit social contacts.</p>
<p>The fact that intervention impact and the probability of averting an outbreak decrease significantly with increasing background infection rate in the community (<xref rid="fig1" ref-type="fig">Figure 1</xref>) suggests a need for alternative housing arrangements for people experiencing homelessness in locations in which community incidence is moderate to high &#x2013; 100&#x2013;500 infections/1,000,000/day, equivalent to 25&#x2013;125 confirmed cases/1,000,000/day (i.e. current San Francisco incidence) assuming four-fold underreporting (see Supplementary Material). In lower background incidence settings, combined daily symptom-based screening, twice-weekly PCR testing, universal masking and relocation of high-risk individuals to non-congregate settings would reduce outbreak risk, and limit incidence of infection and severe disease if outbreaks do occur.</p>
<p>Each infection control strategy is limited in some aspect [<xref ref-type="bibr" rid="c22">22</xref>,<xref ref-type="bibr" rid="c51">51</xref>&#x2013;<xref ref-type="bibr" rid="c55">55</xref>]. Symptom-based screening has very low sensitivity to detect infections early in the clinical course (when people are most infectious), and poor specificity [<xref ref-type="bibr" rid="c12">12</xref>&#x2013;<xref ref-type="bibr" rid="c14">14</xref>,<xref ref-type="bibr" rid="c56">56</xref>]. The impact of routine PCR testing is limited by imperfect PCR sensitivity (&#x223C;75&#x0025;), especially early in the infection course [<xref ref-type="bibr" rid="c19">19</xref>], as well as need for frequent testing and missing onset of infectiousness between testing periods. Other analyses support our finding that testing less than once or twice weekly leaves a high risk of outbreaks (e.g. testing once every two weeks gives a 30&#x0025; lower probability of averting an outbreak than twice-weekly testing, <xref rid="fig3" ref-type="fig">Figure 3</xref>) [<xref ref-type="bibr" rid="c15">15</xref>&#x2013;<xref ref-type="bibr" rid="c17">17</xref>]. However, once- or twice-weekly testing may be financially and logistically infeasible. Similarly, relocation of high-risk persons to independent housing is resource intensive. Frequent testing and universal masking also suffer issues with adherence, which constrains their effectiveness.</p>
<p>This study has a number of limitations. Due to limited data availability, we only calibrated the model to a small number of shelter outbreaks, the <italic>R</italic><sub>0</sub> estimates for which are likely to be higher than for the average shelter due to larger outbreaks being more likely to be reported. The cross-sectional aggregate nature of the majority of the data also led to wide uncertainty intervals around the fitted parameters, without independent identifiability between them (Supplementary Figure 10). Our estimate of the impact of masking is highly sensitive to the assumed effectiveness of masking, which has mixed evidence [<xref ref-type="bibr" rid="c28">28</xref>,<xref ref-type="bibr" rid="c29">29</xref>,<xref ref-type="bibr" rid="c31">31</xref>]. Many uncertainties in the biology of SARS-CoV-2 transmission remain, particularly regarding differential infectiousness over time and by severity of illness, and the relationship of PCR positivity and infectiousness, for which we had to make assumptions based on currently available evidence (see Supplementary Material) [<xref ref-type="bibr" rid="c22">22</xref>,<xref ref-type="bibr" rid="c57">57</xref>,<xref ref-type="bibr" rid="c58">58</xref>].</p>
<p>This study defines conditions that would support safely operating homeless shelters with lower risk of COVID-19 outbreaks and estimates the impact of various interventions on outbreak risk. Our findings demonstrate the need for combined interventions (symptom-based screening, PCR testing, and masking) and regular testing to protect persons experiencing homelessness from COVID-19, while highlighting the limitations of these interventions in preventing outbreaks.</p>
</sec>
<sec sec-type="supplementary-material">
<title>Supporting information</title>
<supplementary-material>
<label>Supplementary Material</label>
<media xlink:href="supplements/203166_file02.pdf" />
</supplementary-material>
</sec>
</body>
<back>
<sec sec-type="data-availability">
<title>Data Availability</title>
<p>All data and code used for the analysis are available at: <ext-link ext-link-type="uri" xlink:href="https://github.com/LloydChapman/COVID_homeless_modelling">https://github.com/LloydChapman/COVID_homeless_modelling</ext-link></p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://github.com/LloydChapman/COVID_homeless_modelling">https://github.com/LloydChapman/COVID_homeless_modelling</ext-link>
</p>
</sec>
<sec id="s5">
<title>Funding</title>
<p>This work was supported by the University of California, San Francisco and the UCSF Benioff Homelessness and Housing Initiative.</p>
</sec>
<ack>
<title>Acknowledgements</title>
<p>We sincerely appreciate the hard work and public health efforts of all those involved in the collection of the data used in this article. LACC would like to thank Renata Retkute, Amanda Minter, Simon Spencer and TJ McKinley for helpful discussions regarding Approximate Bayesian Computation.</p>
</ack>
<sec id="s6">
<title>Disclosures</title>
<p>The authors declare no conflicts of interest or disclosures. NCL has received funding from the World Health Organization for unrelated work.</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>Conceptualization: NCL, LACC</p>
<p>Data Curation: LACC, SNC, AS, CC, TN, EI</p>
<p>Formal Analysis: LACC, NCL</p>
<p>Funding Acquisition: NCL, MK</p>
<p>Investigation: LACC, NCL</p>
<p>Methodology: LACC, NCL</p>
<p>Project Administration: NCL</p>
<p>Resources: NCL</p>
<p>Software: LACC</p>
<p>Supervision: NCL,MK</p>
<p>Visualization: LACC, NCL</p>
<p>Writing &#x2013; Original Draft Preparation: LACC, NCL</p>
<p>Writing &#x2013; Review &#x0026; Editing: All authors</p>
<p>Drs. Lloyd A.C. Chapman and Nathan C. Lo had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><label>1.</label><mixed-citation publication-type="other"><string-name><surname>Henry</surname> <given-names>M</given-names></string-name>, <string-name><surname>Watt</surname> <given-names>R</given-names></string-name>, <string-name><surname>Mahathey</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal> <article-title>The 2019 Annual Homeless Assessment Report (AHAR) to Congress</article-title>. <source>Washington, DC</source>: <year>2020</year>.</mixed-citation></ref>
<ref id="c2"><label>2.</label><mixed-citation publication-type="journal"><string-name><surname>Perri</surname> <given-names>M</given-names></string-name>, <string-name><surname>Dosani</surname> <given-names>N</given-names></string-name>, <string-name><surname>Hwang</surname> <given-names>SW</given-names></string-name>. <article-title>COVID-19 and people experiencing homelessness: challenges and mitigation strategies</article-title>. <source>CMAJ</source> <year>2020</year>; <volume>192</volume>:<fpage>E716</fpage>&#x2013;<lpage>E719</lpage>.</mixed-citation></ref>
<ref id="c3"><label>3.</label><mixed-citation publication-type="website"><string-name><surname>Culhane</surname> <given-names>D</given-names></string-name>, <string-name><surname>Treglia</surname> <given-names>D</given-names></string-name>, <string-name><surname>Steif</surname> <given-names>K</given-names></string-name>, <string-name><surname>Kuhn</surname> <given-names>R</given-names></string-name>, <string-name><surname>Byrne</surname> <given-names>T.</given-names></string-name> <source>Estimated Emergency and Observational/Quarantine Capacity Need for the US Homeless Population Related to COVID-19 Exposure by County; Projected Hospitalizations, Intensive Care Units and Mortality</source>. <year>2020</year>. Available at: <ext-link ext-link-type="uri" xlink:href="https://works.bepress.com/dennis_culhane/237/">https://works.bepress.com/dennis_culhane/237/</ext-link>.</mixed-citation></ref>
<ref id="c4"><label>4.</label><mixed-citation publication-type="website"><string-name><surname>Mosites</surname> <given-names>E</given-names></string-name>, <string-name><surname>Parker</surname> <given-names>EM</given-names></string-name>, <string-name><surname>N Clarke</surname> <given-names>KE</given-names></string-name>, <etal>et al.</etal> <article-title>Assessment of SARS-CoV-2 Infection Prevalence in Homeless Shelters &#x2014; Four U.S</article-title>. <source>Cities</source>, <month>March</month> 27&#x2013;April 15, 2020. <year>2019</year>; <volume>69</volume>. Available at: <ext-link ext-link-type="uri" xlink:href="https://www.medrxiv.org/content/10.1101/2020.04.12.20059618v1">https://www.medrxiv.org/content/10.1101/2020.04.12.20059618v1</ext-link>.</mixed-citation></ref>
<ref id="c5"><label>5.</label><mixed-citation publication-type="website"><string-name><surname>Imbert</surname> <given-names>E</given-names></string-name>, <string-name><surname>Kinley</surname> <given-names>PM</given-names></string-name>, <string-name><surname>Scarborough</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal> <article-title>Coronavirus Disease 2019 (COVID-19) Outbreak in a San Francisco Homeless Shelter</article-title>. <source>Clin Infect Dis</source> <year>2020; Available at</year>: <ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa1071/5879965">https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa1071/5879965</ext-link>. accessed <date-in-citation content-type="access-date">21 August 2020</date-in-citation>.</mixed-citation></ref>
<ref id="c6"><label>6.</label><mixed-citation publication-type="journal"><string-name><surname>Baggett</surname> <given-names>TP</given-names></string-name>, <string-name><surname>Keyes</surname> <given-names>H</given-names></string-name>, <string-name><surname>Sporn</surname> <given-names>N</given-names></string-name>, <string-name><surname>Gaeta</surname> <given-names>JM</given-names></string-name>. <article-title>Prevalence of SARS-CoV-2 Infection in Residents of a Large Homeless Shelter in Boston</article-title>. <source>JAMA - J Am Med Assoc</source> <year>2020</year>; <volume>323</volume>:<fpage>2191</fpage>&#x2013;<lpage>2192</lpage>.</mixed-citation></ref>
<ref id="c7"><label>7.</label><mixed-citation publication-type="journal"><string-name><surname>Tobolowsky</surname> <given-names>FA</given-names></string-name>, <string-name><surname>Gonzales</surname> <given-names>E.</given-names></string-name> <article-title>COVID-19 Outbreak Among Three Affiliated Homeless Service Sites &#x2014; King County, Washington, 2020</article-title>. <source>Morb Mortal Wkly Rep</source> <year>2020</year>; <volume>69</volume>:<fpage>523</fpage>&#x2013;<lpage>526</lpage>.</mixed-citation></ref>
<ref id="c8"><label>8.</label><mixed-citation publication-type="website"><collab>World Health Organization</collab>. <source>Transmission of SARS-CoV-2: implications for infection prevention precautions. 2020</source>. Available at: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/publications/i/item/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations">https://www.who.int/publications/i/item/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations</ext-link>. Accessed <date-in-citation content-type="access-date">11 August 2020</date-in-citation>.</mixed-citation></ref>
<ref id="c9"><label>9.</label><mixed-citation publication-type="website"><collab>Centers for Disease Control</collab>. <source>Interim Considerations for Health Departments for SARS-CoV-2 Testing in Homeless Shelters and Encampments</source>. <year>2020</year>. Available at: <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/community/homeless-shelters/testing.html">https://www.cdc.gov/coronavirus/2019-ncov/community/homeless-shelters/testing.html</ext-link>. accessed <date-in-citation content-type="access-date">11 August 2020</date-in-citation>.</mixed-citation></ref>
<ref id="c10"><label>10.</label><mixed-citation publication-type="website"><collab>Centers for Disease Control</collab>. <source>Investigating and responding to COVID-19 cases at homeless service provider sites</source>. <year>2020</year>. Available at: <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/php/investigating-cases-homeless-shelters.html">https://www.cdc.gov/coronavirus/2019-ncov/php/investigating-cases-homeless-shelters.html</ext-link>. Accessed <date-in-citation content-type="access-date">11 August 2020</date-in-citation>.</mixed-citation></ref>
<ref id="c11"><label>11.</label><mixed-citation publication-type="other"><string-name><surname>Bertozzi</surname> <given-names>AL</given-names></string-name>, <string-name><surname>Franco</surname> <given-names>E</given-names></string-name>, <string-name><surname>Mohler</surname> <given-names>G</given-names></string-name>, <string-name><surname>Short</surname> <given-names>MB</given-names></string-name>, <string-name><surname>Sledge</surname> <given-names>D.</given-names></string-name> <article-title>The challenges of modeling and forecasting the spread of COVID-19</article-title>. <source>Proc Natl Acad Sci</source> <year>2020</year>; :<fpage>202006520</fpage>.</mixed-citation></ref>
<ref id="c12"><label>12.</label><mixed-citation publication-type="journal"><string-name><surname>Gostic</surname> <given-names>KM</given-names></string-name>, <string-name><surname>Gomez</surname> <given-names>ACR</given-names></string-name>, <string-name><surname>Mummah</surname> <given-names>RO</given-names></string-name>, <string-name><surname>Kucharski</surname> <given-names>AJ</given-names></string-name>, <string-name><surname>Lloyd-Smith</surname> <given-names>JO</given-names></string-name>. <article-title>Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19</article-title>. <source>Elife</source> <year>2020</year>; <volume>9</volume>:<fpage>1</fpage>&#x2013;<lpage>18</lpage>.</mixed-citation></ref>
<ref id="c13"><label>13.</label><mixed-citation publication-type="other"><string-name><surname>Roxby</surname> <given-names>AC</given-names></string-name>, <string-name><surname>Greninger</surname> <given-names>AL</given-names></string-name>, <string-name><surname>Hatfield</surname> <given-names>KM</given-names></string-name>, <etal>et al.</etal> <article-title>Outbreak Investigation of COVID-19 among Residents and Staff of an Independent and Assisted Living Community for Older Adults in Seattle, Washington</article-title>. <source>JAMA Intern Med</source> <year>2020</year>; <fpage>98104</fpage>.</mixed-citation></ref>
<ref id="c14"><label>14.</label><mixed-citation publication-type="journal"><string-name><surname>Kimball</surname> <given-names>A</given-names></string-name>, <string-name><surname>Hatfield</surname> <given-names>KM</given-names></string-name>, <string-name><surname>Arons</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> <article-title>Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility &#x2014; King County, Washington, March 2020</article-title>. <source>Morb Mortal Wkly Rep</source> <year>2020</year>; <volume>69</volume>:<fpage>377</fpage>&#x2013;<lpage>381</lpage>.</mixed-citation></ref>
<ref id="c15"><label>15.</label><mixed-citation publication-type="website"><string-name><surname>Larremore</surname> <given-names>DB</given-names></string-name>, <string-name><surname>Wilder</surname> <given-names>B</given-names></string-name>, <string-name><surname>Lester</surname> <given-names>E</given-names></string-name>, <etal>et al.</etal> <article-title>Test sensitivity is secondary to frequency and turnaround time for COVID-19 surveillance</article-title>. <source>medRxiv</source> <year>2020</year>; :2020.06.22.20136309. Available at: <ext-link ext-link-type="uri" xlink:href="https://www.medrxiv.org/content/10.1101/2020.06.22.20136309v2">https://www.medrxiv.org/content/10.1101/2020.06.22.20136309v2</ext-link> <ext-link ext-link-type="uri" xlink:href="https://www.medrxiv.org/content/10.1101/2020.06.22.20136309v2.abstract">https://www.medrxiv.org/content/10.1101/2020.06.22.20136309v2.abstract</ext-link>.</mixed-citation></ref>
<ref id="c16"><label>16.</label><mixed-citation publication-type="journal"><string-name><surname>Paltiel</surname> <given-names>AD</given-names></string-name>, <string-name><surname>Zheng</surname> <given-names>A</given-names></string-name>, <string-name><surname>Walensky</surname> <given-names>RP</given-names></string-name>. <article-title>Assessment of SARS-CoV-2 Screening Strategies to Permit the Safe Reopening of College Campuses in the United States</article-title>. <source>JAMA Netw Open</source> <year>2020</year>; <volume>3</volume>:<fpage>e2016818</fpage>. Available at: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/32735339">http://www.ncbi.nlm.nih.gov/pubmed/32735339</ext-link>.</mixed-citation></ref>
<ref id="c17"><label>17.</label><mixed-citation publication-type="website"><string-name><surname>Chin</surname> <given-names>ET</given-names></string-name>, <string-name><surname>Huynh</surname> <given-names>BQ</given-names></string-name>, <string-name><surname>Murrill</surname> <given-names>M</given-names></string-name>, <string-name><surname>Basu</surname> <given-names>S</given-names></string-name>, <string-name><surname>Lo</surname> <given-names>NC</given-names></string-name>. <article-title>Frequency of routine testing for COVID-19 in high-risk environments to reduce workplace outbreaks</article-title>. <source>medRxiv</source> <year>2020</year>; :2020.04.30.20087015. Available at: <ext-link ext-link-type="uri" xlink:href="http://medrxiv.org/content/early/2020/06/22/2020.04.30.20087015.abstract">http://medrxiv.org/content/early/2020/06/22/2020.04.30.20087015.abstract</ext-link>.</mixed-citation></ref>
<ref id="c18"><label>18.</label><mixed-citation publication-type="other"><string-name><surname>Arevalo-Rodriguez</surname> <given-names>I</given-names></string-name>, <string-name><surname>Buitrago-Garcia</surname> <given-names>D</given-names></string-name>, <string-name><surname>Simancas-Racines</surname> <given-names>D</given-names></string-name>, <etal>et al.</etal> <article-title>False-Negative Results of Initial RT-PCR Assays for Covid-19: a Systematic Review</article-title>. <year>2020</year>; :<fpage>1</fpage>&#x2013;<lpage>26</lpage>.</mixed-citation></ref>
<ref id="c19"><label>19.</label><mixed-citation publication-type="other"><string-name><surname>Kucirka</surname> <given-names>LM</given-names></string-name>, <string-name><surname>Lauer</surname> <given-names>SA</given-names></string-name>, <string-name><surname>Laeyendecker</surname> <given-names>O</given-names></string-name>, <string-name><surname>Boon</surname> <given-names>D</given-names></string-name>, <string-name><surname>Lessler</surname> <given-names>J.</given-names></string-name> <article-title>Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction&#x2013;Based SARS-CoV-2 Tests by Time Since Exposure</article-title>. <source>Ann Intern Med</source> <year>2020</year>;</mixed-citation></ref>
<ref id="c20"><label>20.</label><mixed-citation publication-type="journal"><string-name><surname>Watson</surname> <given-names>J</given-names></string-name>, <string-name><surname>Whiting</surname> <given-names>PF</given-names></string-name>, <string-name><surname>Brush</surname> <given-names>JE</given-names></string-name>. <article-title>Interpreting a covid-19 test result</article-title>. <source>BMJ</source> <year>2020</year>; <volume>369</volume>:<fpage>1</fpage>&#x2013;<lpage>7</lpage>. Available at: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/bmj.m1808">http://dx.doi.org/doi:10.1136/bmj.m1808</ext-link>.</mixed-citation></ref>
<ref id="c21"><label>21.</label><mixed-citation publication-type="other"><string-name><surname>Padhye</surname> <given-names>NS</given-names></string-name>. <article-title>Reconstructed diagnostic sensitivity and specificity of the RT-PCR test for COVID-19</article-title>. <source>medRxiv</source> <year>2020</year>; 19:2020.04.24.20078949. Available at: <ext-link ext-link-type="uri" xlink:href="http://medrxiv.org/lookup/doi/10.1101/2020.04.24.20078949">http://medrxiv.org/lookup/doi/10.1101/2020.04.24.20078949</ext-link>.</mixed-citation></ref>
<ref id="c22"><label>22.</label><mixed-citation publication-type="journal"><string-name><surname>He</surname> <given-names>X</given-names></string-name>, <string-name><surname>Lau</surname> <given-names>EHY</given-names></string-name>, <string-name><surname>Wu</surname> <given-names>P</given-names></string-name>, <etal>et al.</etal> <article-title>Temporal dynamics in viral shedding and transmissibility of COVID-19</article-title>. <source>Nat Med</source> <year>2020</year>; <volume>26</volume>:<fpage>672</fpage>&#x2013;<lpage>675</lpage>.</mixed-citation></ref>
<ref id="c23"><label>23.</label><mixed-citation publication-type="journal"><string-name><surname>W&#x00F6;lfel</surname> <given-names>R</given-names></string-name>, <string-name><surname>Corman</surname> <given-names>VM</given-names></string-name>, <string-name><surname>Guggemos</surname> <given-names>W</given-names></string-name>, <etal>et al.</etal> <article-title>Virological assessment of hospitalized patients with COVID-2019</article-title>. <source>Nature</source> <year>2020</year>; <volume>581</volume>:<fpage>465</fpage>&#x2013;<lpage>469</lpage>.</mixed-citation></ref>
<ref id="c24"><label>24.</label><mixed-citation publication-type="journal"><string-name><surname>To</surname> <given-names>KKW</given-names></string-name>, <string-name><surname>Tsang</surname> <given-names>OTY</given-names></string-name>, <string-name><surname>Leung</surname> <given-names>WS</given-names></string-name>, <etal>et al.</etal> <article-title>Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study</article-title>. <source>Lancet Infect Dis</source> <year>2020</year>; <volume>20</volume>:<fpage>565</fpage>&#x2013;<lpage>574</lpage>. Available at: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S1473-3099(20)30196-1">http://dx.doi.org/10.1016/S1473-3099(20)30196-1</ext-link>.</mixed-citation></ref>
<ref id="c25"><label>25.</label><mixed-citation publication-type="journal"><string-name><surname>Zhou</surname> <given-names>F</given-names></string-name>, <string-name><surname>Yu</surname> <given-names>T</given-names></string-name>, <string-name><surname>Du</surname> <given-names>R</given-names></string-name>, <etal>et al.</etal> <article-title>Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study</article-title>. <source>Lancet</source> <year>2020</year>; <volume>395</volume>:<fpage>1054</fpage>&#x2013;<lpage>1062</lpage>. Available at: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S0140-6736(20)30566-3">http://dx.doi.org/10.1016/S0140-6736(20)30566-3</ext-link>.</mixed-citation></ref>
<ref id="c26"><label>26.</label><mixed-citation publication-type="journal"><string-name><surname>Xiao</surname> <given-names>AT</given-names></string-name>, <string-name><surname>Tong</surname> <given-names>YX</given-names></string-name>, <string-name><surname>Gao</surname> <given-names>C</given-names></string-name>, <string-name><surname>Zhu</surname> <given-names>L</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>YJ</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>S.</given-names></string-name> <article-title>Dynamic profile of RT-PCR findings from 301 COVID-19 patients in Wuhan, China: A descriptive study</article-title>. <source>J Clin Virol</source> <year>2020</year>; <volume>127</volume>:<fpage>0</fpage>&#x2013;<lpage>6</lpage>.</mixed-citation></ref>
<ref id="c27"><label>27.</label><mixed-citation publication-type="journal"><string-name><surname>Zou</surname> <given-names>L</given-names></string-name>, <string-name><surname>Ruan</surname> <given-names>F</given-names></string-name>, <string-name><surname>Huang</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> <article-title>SARS-CoV-2 viral load in upper respiratory specimens of infected patients</article-title>. <source>N Engl J Med</source> <year>2020</year>; <volume>382</volume>:<fpage>1177</fpage>&#x2013;<lpage>1179</lpage>.</mixed-citation></ref>
<ref id="c28"><label>28.</label><mixed-citation publication-type="journal"><string-name><surname>Leung</surname> <given-names>NHL</given-names></string-name>, <string-name><surname>Chu</surname> <given-names>DKW</given-names></string-name>, <string-name><surname>Shiu</surname> <given-names>EYC</given-names></string-name>, <etal>et al.</etal> <article-title>Respiratory virus shedding in exhaled breath and efficacy of face masks</article-title>. <source>Nat Med</source> <year>2020</year>; <volume>26</volume>:<fpage>676</fpage>&#x2013;<lpage>680</lpage>. Available at: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/s41591-020-0843-2">http://dx.doi.org/10.1038/s41591-020-0843-2</ext-link>.</mixed-citation></ref>
<ref id="c29"><label>29.</label><mixed-citation publication-type="journal"><string-name><surname>MacIntyre</surname> <given-names>CR</given-names></string-name>, <string-name><surname>Chughtai</surname> <given-names>AA</given-names></string-name>. <article-title>Facemasks for the prevention of infection in healthcare and community settings</article-title>. <source>BMJ</source> <year>2015</year>; <volume>350</volume>:<fpage>1</fpage>&#x2013;<lpage>12</lpage>.</mixed-citation></ref>
<ref id="c30"><label>30.</label><mixed-citation publication-type="journal"><string-name><surname>MacIntyre</surname> <given-names>CR</given-names></string-name>, <string-name><surname>Chughtai</surname> <given-names>AA</given-names></string-name>. <article-title>A rapid systematic review of the efficacy of face masks and respirators against coronaviruses and other respiratory transmissible viruses for the community, healthcare workers and sick patients</article-title>. <source>Int J Nurs Stud</source> <year>2020</year>; <volume>108</volume>:<fpage>0</fpage>&#x2013;<lpage>5</lpage>.</mixed-citation></ref>
<ref id="c31"><label>31.</label><mixed-citation publication-type="other"><string-name><surname>Brainard</surname> <given-names>JS</given-names></string-name>, <string-name><surname>Jones</surname> <given-names>N</given-names></string-name>, <string-name><surname>Lake</surname> <given-names>I</given-names></string-name>, <string-name><surname>Hooper</surname> <given-names>L</given-names></string-name>, <string-name><surname>Hunter</surname> <given-names>P.</given-names></string-name> <source>Facemasks and similar barriers to prevent respiratory illness such as COVID-19: A rapid systematic review</source>. <year>2020</year>;</mixed-citation></ref>
<ref id="c32"><label>32.</label><mixed-citation publication-type="website"><string-name><given-names>Chan</given-names> <surname>JF-WW</surname></string-name>, <string-name><surname>Yuan</surname> <given-names>S</given-names></string-name>, <string-name><surname>Zhang</surname> <given-names>AJ</given-names></string-name>, <etal>et al.</etal> <article-title>Surgical mask partition reduces the risk of non-contact transmission in a golden Syrian hamster model for Coronavirus Disease 2019 (COVID-19)</article-title>. <source>Clin Infect Dis</source> <year>2020; Available at</year>: <ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa644/5848814">https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa644/5848814</ext-link>. Accessed <date-in-citation content-type="access-date">11 August 2020</date-in-citation>.</mixed-citation></ref>
<ref id="c33"><label>33.</label><mixed-citation publication-type="website"><string-name><surname>Mueller</surname> <given-names>A</given-names></string-name>, <string-name><surname>Eden</surname> <given-names>M</given-names></string-name>, <string-name><surname>Oakes</surname> <given-names>J</given-names></string-name>, <string-name><surname>Bellini</surname> <given-names>C</given-names></string-name>, <string-name><surname>Fernandez</surname> <given-names>L.</given-names></string-name> <article-title>Quantitative Method for Comparative Assessment of Particle Removal Efficiency of Fabric Masks as Alternatives to Standard Surgical Masks for PPE</article-title>. <source>Matter</source> <year>2020; Available at</year>: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.matt.2020.07.006">https://doi.org/10.1016/j.matt.2020.07.006</ext-link>.</mixed-citation></ref>
<ref id="c34"><label>34.</label><mixed-citation publication-type="website"><collab>Axios, Ipsos. Axios/Ipsos Poll Wave 14</collab>. <year>2020; Available at</year>: <ext-link ext-link-type="uri" xlink:href="https://www.ipsos.com/en-us/news-polls/axios-ipsos-coronavirus-index">https://www.ipsos.com/en-us/news-polls/axios-ipsos-coronavirus-index</ext-link>.</mixed-citation></ref>
<ref id="c35"><label>35.</label><mixed-citation publication-type="journal"><string-name><surname>Betsch</surname> <given-names>C</given-names></string-name>, <string-name><surname>Korn</surname> <given-names>L</given-names></string-name>, <string-name><surname>Sprengholz</surname> <given-names>P</given-names></string-name>, <etal>et al.</etal> <article-title>Social and behavioral consequences of mask policies during the COVID-19 pandemic</article-title>. <source>Proc Natl Acad Sci U S A</source> <year>2020</year>; <volume>117</volume>:<fpage>21851</fpage>&#x2013;<lpage>21853</lpage>.</mixed-citation></ref>
<ref id="c36"><label>36.</label><mixed-citation publication-type="website"><string-name><surname>Haischer</surname> <given-names>MH</given-names></string-name>, <string-name><surname>Beilfuss</surname> <given-names>R</given-names></string-name>, <string-name><surname>Rose Hart</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> Who <article-title>is wearing a mask? Gender-, age-, and location-related differences during the COVID-19 pandemic</article-title>. <source>medRxiv</source> <year>2020</year>; :2020.07.13.20152736. Available at: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1101/2020.07.13.20152736">https://doi.org/10.1101/2020.07.13.20152736</ext-link>.</mixed-citation></ref>
<ref id="c37"><label>37.</label><mixed-citation publication-type="website"><collab>Managing Investigations During an Outbreak &#x007C; CDC</collab>. Available at: <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/coronavirus/2019-ncov/php/contact-tracing/contact-tracing-plan/outbreaks.html">https://www.cdc.gov/coronavirus/2019-ncov/php/contact-tracing/contact-tracing-plan/outbreaks.html</ext-link>. accessed <date-in-citation content-type="access-date">11 August 2020</date-in-citation>.</mixed-citation></ref>
<ref id="c38"><label>38.</label><mixed-citation publication-type="website"><string-name><surname>Patel</surname> <given-names>M</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>AD</given-names></string-name>, <string-name><surname>Clemmons</surname> <given-names>NS</given-names></string-name>, <etal>et al.</etal> <source>National Update on Measles Cases and Outbreaks &#x2014; United States, January 1&#x2013;</source><month>October</month> 1, <year>2019</year>. Available at: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/immunization/policy/">https://www.who.int/immunization/policy/</ext-link>.</mixed-citation></ref>
<ref id="c39"><label>39.</label><mixed-citation publication-type="journal"><string-name><surname>Liu</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Gayle</surname> <given-names>AA</given-names></string-name>, <string-name><surname>Wilder-Smith</surname> <given-names>A</given-names></string-name>, <string-name><surname>Rockl&#x00F6;</surname> <given-names>v</given-names></string-name> <string-name><given-names>J.</given-names> <surname>Th</surname></string-name><article-title>e reproductive number of COVID-19 is higher compared to SARS coronavirus</article-title>. <source>J Travel Med</source> <year>2020</year>; <volume>27</volume>:<fpage>1</fpage>&#x2013;<lpage>4</lpage>.</mixed-citation></ref>
<ref id="c40"><label>40.</label><mixed-citation publication-type="journal"><string-name><surname>Davies</surname> <given-names>NG</given-names></string-name>, <string-name><surname>Kucharski</surname> <given-names>AJ</given-names></string-name>, <string-name><surname>Eggo</surname> <given-names>RM</given-names></string-name>, <etal>et al.</etal> <article-title>Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study</article-title>. <source>Lancet Public Heal</source> <year>2020</year>; :<fpage>e375</fpage>&#x2013;<lpage>e385</lpage>.</mixed-citation></ref>
<ref id="c41"><label>41.</label><mixed-citation publication-type="other"><string-name><surname>Endo</surname> <given-names>A</given-names></string-name>, <string-name><surname>Abbott</surname> <given-names>S</given-names></string-name>, <string-name><surname>Kucharski</surname> <given-names>AJ</given-names></string-name>, <string-name><surname>Funk</surname> <given-names>S.</given-names></string-name> <source>Estimating the overdispersion in COVID-19 transmission using outbreak sizes outside China</source>. <year>2020</year>; :<fpage>1</fpage>&#x2013;<lpage>13</lpage>.</mixed-citation></ref>
<ref id="c42"><label>42.</label><mixed-citation publication-type="website"><collab>MIDAS Network</collab>. <source>COVID-19 parameter estimates</source>. Available at: <ext-link ext-link-type="uri" xlink:href="https://github.com/midas-network/COVID-19/tree/master/parameter_estimates/2019_novel_coronavirus">https://github.com/midas-network/COVID-19/tree/master/parameter_estimates/2019_novel_coronavirus</ext-link>. Accessed <date-in-citation content-type="access-date">11 August 2020</date-in-citation>.</mixed-citation></ref>
<ref id="c43"><label>43.</label><mixed-citation publication-type="website"><string-name><surname>Lau</surname> <given-names>MS</given-names></string-name>, <string-name><surname>Grenfell</surname> <given-names>B</given-names></string-name>, <string-name><surname>Nelson</surname> <given-names>K</given-names></string-name>, <string-name><surname>Lopman</surname> <given-names>B.</given-names></string-name> <article-title>Characterizing super-spreading events and age-specific infectivity of COVID-19 transmission in Georgia, USA</article-title>. <source>medRxiv</source> <year>2020</year>; :2020.06.20.20130476. Available at: <ext-link ext-link-type="uri" xlink:href="https://www.medrxiv.org/content/10.1101/2020.06.20.20130476v2">https://www.medrxiv.org/content/10.1101/2020.06.20.20130476v2</ext-link> <ext-link ext-link-type="uri" xlink:href="https://www.medrxiv.org/content/10.1101/2020.06.20.20130476v2.abstract">https://www.medrxiv.org/content/10.1101/2020.06.20.20130476v2.abstract</ext-link>.</mixed-citation></ref>
<ref id="c44"><label>44.</label><mixed-citation publication-type="journal"><string-name><surname>Szablewski</surname> <given-names>CM</given-names></string-name>, <string-name><surname>Chang</surname> <given-names>KT</given-names></string-name>, <string-name><surname>Brown</surname> <given-names>MM</given-names></string-name>, <etal>et al.</etal> <article-title>SARS-CoV-2 Transmission and Infection Among Attendees of an Overnight Camp - Georgia, June 2020</article-title>. <source>Morb Mortal Wkly Rep</source> <year>2020</year>; <volume>69</volume>:<fpage>1023</fpage>&#x2013;<lpage>1025</lpage>. Available at: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/32759921">http://www.ncbi.nlm.nih.gov/pubmed/32759921</ext-link>.</mixed-citation></ref>
<ref id="c45"><label>45.</label><mixed-citation publication-type="journal"><string-name><surname>James</surname> <given-names>A</given-names></string-name>, <string-name><surname>Eagle</surname> <given-names>L</given-names></string-name>, <string-name><surname>Phillips</surname> <given-names>C</given-names></string-name>, <etal>et al.</etal> <article-title>High COVID-19 Attack Rate Among Attendees at Events at a Church &#x2014; Arkansas, March 2020</article-title>. <source>Morb Mortal Wkly Rep</source> <year>2020</year>; <volume>69</volume>:<fpage>632</fpage>&#x2013;<lpage>635</lpage>.</mixed-citation></ref>
<ref id="c46"><label>46.</label><mixed-citation publication-type="journal"><string-name><surname>County</surname> <given-names>S</given-names></string-name>, <string-name><surname>Hamner</surname> <given-names>L</given-names></string-name>, <string-name><surname>Dubbel</surname> <given-names>P</given-names></string-name>, <etal>et al.</etal> <article-title>High SARS-CoV-2 Attack Rate Following Exposure at a Choir Practice</article-title>. <source>Morb Mortal Wkly Rep</source> <year>2020</year>; <volume>69</volume>:<fpage>606</fpage>&#x2013;<lpage>610</lpage>. Available at: <ext-link ext-link-type="uri" xlink:href="https://www.cdc.gov/mmwr/volumes/69/wr/mm6919e6.htm">https://www.cdc.gov/mmwr/volumes/69/wr/mm6919e6.htm</ext-link>.</mixed-citation></ref>
<ref id="c47"><label>47.</label><mixed-citation publication-type="website"><collab>City of San Diego</collab>. <source>Operation Shelter to Home</source>. <year>2020</year>. Available at: <ext-link ext-link-type="uri" xlink:href="https://www.sandiego.gov/coronavirus/sheltertohome">https://www.sandiego.gov/coronavirus/sheltertohome</ext-link>. Accessed <date-in-citation content-type="access-date">21 August 2020</date-in-citation>.</mixed-citation></ref>
<ref id="c48"><label>48.</label><mixed-citation publication-type="journal"><string-name><surname>Courtemanche</surname> <given-names>C</given-names></string-name>, <string-name><surname>Garuccio</surname> <given-names>J</given-names></string-name>, Le A, <string-name><surname>Pinkston</surname> <given-names>J</given-names></string-name>, <string-name><surname>Yelowitz</surname> <given-names>A.</given-names></string-name> <article-title>Strong Social Distancing Measures In The United States Reduced The COVID-19 Growth Rate</article-title>. <source>Health Aff</source> <year>2020</year>; <volume>39</volume>:<fpage>1237</fpage>&#x2013;<lpage>1246</lpage>.</mixed-citation></ref>
<ref id="c49"><label>49.</label><mixed-citation publication-type="journal"><string-name><surname>Prem</surname> <given-names>K</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Russell</surname> <given-names>TW</given-names></string-name>, <etal>et al.</etal> <article-title>The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study</article-title>. <source>Lancet Public Heal</source> <year>2020</year>; <volume>5</volume>:<fpage>e261</fpage>&#x2013;<lpage>e270</lpage>.</mixed-citation></ref>
<ref id="c50"><label>50.</label><mixed-citation publication-type="journal"><string-name><surname>Jarvis</surname> <given-names>CI</given-names></string-name>, <string-name><surname>Van Zandvoort</surname> <given-names>K</given-names></string-name>, <string-name><surname>Gimma</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal> <article-title>Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK</article-title>. <source>BMC Med</source> <year>2020</year>; <volume>18</volume>:<fpage>1</fpage>&#x2013;<lpage>10</lpage>.</mixed-citation></ref>
<ref id="c51"><label>51.</label><mixed-citation publication-type="journal"><string-name><surname>Furukawa</surname> <given-names>NW</given-names></string-name>, <string-name><surname>Furukawa</surname> <given-names>NW</given-names></string-name>, <string-name><surname>Brooks</surname> <given-names>JT</given-names></string-name>, <string-name><surname>Sobel</surname> <given-names>J.</given-names></string-name> <article-title>Evidence Supporting Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 while Presymptomatic or Asymptomatic</article-title>. <source>Emerg Infect Dis</source> <year>2020</year>; <volume>26</volume>:<fpage>E1</fpage>&#x2013;<lpage>E6</lpage>.</mixed-citation></ref>
<ref id="c52"><label>52.</label><mixed-citation publication-type="journal"><string-name><surname>Arons</surname> <given-names>MM</given-names></string-name>, <string-name><surname>Hatfield</surname> <given-names>KM</given-names></string-name>, <string-name><surname>Reddy</surname> <given-names>SC</given-names></string-name>, <etal>et al.</etal> <article-title>Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility</article-title>. <source>N Engl J Med</source> <year>2020</year>; <volume>382</volume>:<fpage>2081</fpage>&#x2013;<lpage>2090</lpage>.</mixed-citation></ref>
<ref id="c53"><label>53.</label><mixed-citation publication-type="journal"><string-name><surname>Tindale</surname> <given-names>LC</given-names></string-name>, <string-name><surname>Stockdale</surname> <given-names>JE</given-names></string-name>, <string-name><surname>Coombe</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> <article-title>Evidence for transmission of COVID-19 prior to symptom onset</article-title>. <source>Elife</source> <year>2020</year>; <volume>9</volume>:<fpage>1</fpage>&#x2013;<lpage>34</lpage>.</mixed-citation></ref>
<ref id="c54"><label>54.</label><mixed-citation publication-type="website"><string-name><surname>Casey</surname> <given-names>M</given-names></string-name>, <string-name><surname>Griffin</surname> <given-names>J</given-names></string-name>, <string-name><surname>McAloon</surname> <given-names>CG</given-names></string-name>, <etal>et al.</etal> <article-title>Estimating pre-symptomatic transmission of COVID-19: a secondary analysis using published data</article-title>. <source>medRxiv</source> <year>2020</year>; :2020.05.08.20094870. Available at: <ext-link ext-link-type="uri" xlink:href="http://medrxiv.org/lookup/doi/10.1101/2020.05.08.20094870">http://medrxiv.org/lookup/doi/10.1101/2020.05.08.20094870</ext-link>.</mixed-citation></ref>
<ref id="c55"><label>55.</label><mixed-citation publication-type="journal"><string-name><surname>Li</surname> <given-names>R</given-names></string-name>, <string-name><surname>Pei</surname> <given-names>S</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>B</given-names></string-name>, <etal>et al.</etal> <article-title>Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)</article-title>. <source>Science (80-</source>) <year>2020</year>; <volume>368</volume>:<fpage>489</fpage>&#x2013;<lpage>493</lpage>.</mixed-citation></ref>
<ref id="c56"><label>56.</label><mixed-citation publication-type="journal"><string-name><surname>Arima</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Kutsuna</surname> <given-names>S</given-names></string-name>, <string-name><surname>Shimada</surname> <given-names>T</given-names></string-name>, <etal>et al.</etal> <article-title>Severe Acute Respiratory Syndrome Coronavirus 2 Infection among Returnees to Japan from Wuhan, China, 2020</article-title>. <source>Emerg Infect Dis</source> <year>2020</year>; <volume>26</volume>:<fpage>1596</fpage>&#x2013;<lpage>1600</lpage>. Available at: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJMc2001899">https://doi.org/10.1056/NEJMc2001899</ext-link>. Accessed <date-in-citation content-type="access-date">11 August 2020</date-in-citation>.</mixed-citation></ref>
<ref id="c57"><label>57.</label><mixed-citation publication-type="website"><string-name><surname>Bullard</surname> <given-names>J</given-names></string-name>, <string-name><surname>Dust</surname> <given-names>K</given-names></string-name>, <string-name><surname>Funk</surname> <given-names>D</given-names></string-name>, <etal>et al.</etal> <article-title>Predicting infectious SARS-CoV-2 from diagnostic samples</article-title>. <source>Clin Infect Dis</source> <year>2020; Available at</year>: <ext-link ext-link-type="uri" xlink:href="https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa638/5842165">https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa638/5842165</ext-link>. Accessed <date-in-citation content-type="access-date">11 August 2020</date-in-citation>.</mixed-citation></ref>
<ref id="c58"><label>58.</label><mixed-citation publication-type="other"><string-name><surname>Long</surname> <given-names>QX</given-names></string-name>, <string-name><surname>Tang</surname> <given-names>XJ</given-names></string-name>, <string-name><surname>Shi</surname> <given-names>QL</given-names></string-name>, <etal>et al.</etal> <article-title>Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections</article-title>. <source>Nat Med</source> <year>2020</year>;</mixed-citation></ref>
<ref id="c59"><label>59.</label><mixed-citation publication-type="journal"><string-name><surname>Chang</surname> <given-names>D</given-names></string-name>, <string-name><surname>Mo</surname> <given-names>G</given-names></string-name>, <string-name><surname>Yuan</surname> <given-names>X</given-names></string-name>, <etal>et al.</etal> <article-title>Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection</article-title>. <source>Am J Respir Crit Care Med</source> <year>2020</year>; <volume>201</volume>:<fpage>1150</fpage>&#x2013;<lpage>1152</lpage>.</mixed-citation></ref>
<ref id="c60"><label>60.</label><mixed-citation publication-type="journal"><string-name><surname>Chen</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>A</given-names></string-name>, <string-name><surname>Yi</surname> <given-names>B</given-names></string-name>, <etal>et al.</etal> <article-title>Epidemiological characteristics of infection in COVID-19 close contacts in Ningbo city</article-title>. <source>Chinese J Epidemiol</source> <year>2020</year>; <volume>41</volume>:<fpage>667</fpage>&#x2013;<lpage>671</lpage>.</mixed-citation></ref>
<ref id="c61"><label>61.</label><mixed-citation publication-type="journal"><string-name><surname>Davies</surname> <given-names>NG</given-names></string-name>, <string-name><surname>Klepac</surname> <given-names>P</given-names></string-name>, <string-name><surname>Liu</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Prem</surname> <given-names>K</given-names></string-name>, <string-name><surname>Jit</surname> <given-names>M</given-names></string-name>, <string-name><surname>Eggo</surname> <given-names>RM</given-names></string-name>. <article-title>Age-dependent effects in the transmission and control of COVID-19 epidemics</article-title>. <source>medRxiv</source> <year>2020</year>;</mixed-citation></ref>
<ref id="c62"><label>62.</label><mixed-citation publication-type="website"><collab>King County Department of Public Health</collab>. <source>Daily COVID-19 outbreak summary - King County</source>. <year>2020</year>. Available at: <ext-link ext-link-type="uri" xlink:href="https://www.kingcounty.gov/depts/health/covid-19/data/daily-summary.aspx">https://www.kingcounty.gov/depts/health/covid-19/data/daily-summary.aspx</ext-link>. Accessed <date-in-citation content-type="access-date">13 August 2020</date-in-citation>.</mixed-citation></ref>
<ref id="c63"><label>63.</label><mixed-citation publication-type="website"><collab>City of Boston</collab>. <source>COVID-19 Case Tracker</source>. <year>2020</year>. Available at: <ext-link ext-link-type="uri" xlink:href="https://dashboard.cityofboston.gov/t/Guest_Access_Enabled/views/COVID-19/Dashboard1?:showAppBanner=false&#x0026;:display_count=n&#x0026;:showVizHome=n&#x0026;:origin=viz_share_link&#x0026;:isGuestRedirectFromVizportal=y&#x0026;:embed=y">https://dashboard.cityofboston.gov/t/Guest_Access_Enabled/views/COVID-19/Dashboard1?:showAppBanner=false&#x0026;:display_count=n&#x0026;:showVizHome=n&#x0026;:origin=viz_share_link&#x0026;:isGuestRedirectFromVizportal=y&#x0026;:embed=y</ext-link>. Accessed <date-in-citation content-type="access-date">13 August 2020</date-in-citation>.</mixed-citation></ref>
<ref id="c64"><label>64.</label><mixed-citation publication-type="website"><collab><italic>San Francisco Department of Public Health</italic></collab>. <source>COVID-19 Cases Summarized by Date, Transmission and Case Disposition - City and County of San Francisco</source>. <year>2020</year>. Available at: <ext-link ext-link-type="uri" xlink:href="https://data.sfgov.org/COVID-19/COVID-19-Cases-Summarized-by-Date-Transmission-and/tvq9-ec9w">https://data.sfgov.org/COVID-19/COVID-19-Cases-Summarized-by-Date-Transmission-and/tvq9-ec9w</ext-link>. Accessed <date-in-citation content-type="access-date">13 August 2020</date-in-citation>.</mixed-citation></ref>
</ref-list>
</back>
</article>